Strategy (MSTR) Founder Michael Saylor Pushes Back On Bitcoin Protocol Change BIP 110

  • Michael Saylor, founder of Strategy (NasdaqGS:MSTR), has publicly opposed the proposed Bitcoin protocol change known as BIP-110.
  • His comments focus on protecting Bitcoin’s existing consensus rules and caution against protocol changes that serve narrow factions.
  • The remarks have intensified an ongoing industry debate about how Bitcoin governance should handle protocol-level changes.

For investors watching Strategy, Saylor’s stance comes as the stock trades at $93.33 after a decline of 40.6% year to date and 76.4% over the past year. Those moves contrast with a 129.1% gain over three years and 39.1% over five years. The mix of shorter term weakness and longer term gains frames how investors might think about the company’s exposure to Bitcoin policy debates.

Saylor’s position on BIP-110 reinforces Strategy’s identity as a high conviction advocate for Bitcoin’s current consensus framework. For shareholders, the key question is how this governance role fits with the company’s long term Bitcoin-focused thesis and risk profile. The outcome of the BIP-110 discussion could inform how you assess governance risk alongside price volatility when you look at NasdaqGS:MSTR.

Stay updated on the most important news stories for Strategy by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Strategy.

NasdaqGS:MSTR Earnings & Revenue Growth as at Jul 2026
NasdaqGS:MSTR Earnings & Revenue Growth as at Jul 2026

📰 Beyond the headline: 2 risks and 1 thing going right for Strategy that every investor should see.

Advertisement

Quick Assessment

  • ✅ Price vs Analyst Target: Strategy trades at US$93.33 compared with an analyst price target of US$303.64; this represents a gap of roughly 67%.
  • ⚖️ Simply Wall St Valuation: Simply Wall St DCF data is not available, so there is no internal fair value check for Strategy here.
  • ✅ Recent Momentum: The stock has inched up 0.7% over the past 30 days, suggesting the BIP-110 debate has not driven a sharp short term move.

There's only one way to know the right time to buy, sell or hold Strategy. Head to Simply Wall St's company report for the latest analysis of Strategy's Fair Value.

Key Considerations

  • 📊 Saylor’s opposition to BIP-110 highlights Strategy’s role as a vocal Bitcoin governance participant, which you may want to factor in alongside its treasury exposure.
  • 📊 Watch how the BIP-110 discussion shapes sentiment around Bitcoin protocol stability and compare that with Strategy’s share price versus the US$303.64 analyst target.
  • ⚠️ Recent volatility, shareholder dilution over the past year and a high profile stance in protocol debates all add governance and sentiment risk to assess.

Dig Deeper

For the full picture including more risks and rewards, check out the complete Strategy analysis. Alternatively, you can check out the community page for Strategy to see how other investors believe this latest news will impact the company's narrative.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqGS:MSTR

Strategy

Operates as a bitcoin treasury company in the United States, Europe, the Middle East, Africa, and internationally.

Excellent balance sheet with moderate growth potential.

Advertisement

Weekly Picks

CE
Ceazar
SPAI logo
Ceazar on Sparc AI ·

When GPS fails: this small cap is fixing a $54B drone problem

Fair Value:CA$5.2554.7% undervalued
107 users have followed this narrative
0 users have commented on this narrative
23 users have liked this narrative
BL
BlackGoat
IREN logo
BlackGoat on IREN ·

IREN's Bold Moves in Sustainable Bitcoin Mining & AI Data Centers

Fair Value:US$71.4859.0% undervalued
213 users have followed this narrative
8 users have commented on this narrative
32 users have liked this narrative
HE
HedgeY
ARM logo
HedgeY on Arm Holdings ·

The Architecture Layer of AI Computing - But Priced Like the Future Already Arrived?

Fair Value:US$43047.7% undervalued
20 users have followed this narrative
1 users have commented on this narrative
6 users have liked this narrative
HI
Hidden_Rock_Capital
FISV logo
Hidden_Rock_Capital on Fiserv ·

Temporary "perfect storm" leads to opportunity to buy financial services leader for less than 5x long-term earnings

Fair Value:US$119.9953.6% undervalued
25 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative

Updated Narratives

HE
NGXGROUP logo
Henrynuke03 on Nigerian Exchange Group ·

Future Growth Awaits NGXGROUP with New High-Profile Listings

Fair Value:₦221.1732.3% undervalued
7 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
PR
PrashhD
AURIONPRO logo
PrashhD on Aurionpro Solutions ·

Aurionpro Solutions: Is the Market Mispricing One of India's Most Interesting Fintech Product Companies?

Fair Value:₹1k27.1% undervalued
1 users have followed this narrative
1 users have commented on this narrative
0 users have liked this narrative
NE
LOT logo
newsfinder11221 on Lotus Technology ·

Lotus Technology: A Technology-Driven Luxury EV Brand with a Promising Turnaround Story

Fair Value:US$2.464.0% undervalued
1 users have followed this narrative
2 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28032.1% undervalued
211 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.917.0% undervalued
97 users have followed this narrative
0 users have commented on this narrative
7 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6510.2% undervalued
74 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0